Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin

发表于 2026-10-19 22:04:19

期刊：Frontiers in Immunology

文献作者：Rifei Li; Xinjie Zhu; Peng Zhou; Yuehua Qiao; Yinqian Li; Yice Xu; Xi Shi

出版日期：--

DOI号：10.3389/fimmu.2022.852700

下载链接：https://www.frontiersin.org/articles/10.3389/fimmu.2022.852700/full

文献链接：https://doi.org/10.3389/fimmu.2022.852700

当前文献来源于 <span style="color: #0E8ED8">Frontiers Media SA</span>。

备注信息：

发表于 2026-10-19 22:04:20

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Frontiers Media] Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Frontiers Media] Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin 一键复制